Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
2023-05-02
2023-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TRIP-Patch vs the Rigiscan
NCT05219071
Safety, Efficacy and Usage Compliance of the Silk'n Tightra Device
NCT03900143
Wetness Sensing System
NCT05454813
Usability Study of the Focus Touch™ Conception System: Semen Collection
NCT01585012
TRIP-patch vs Duplex
NCT06402097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FirmTech Tech Ring
Participants will utilize the FirmTech Tech Ring at least twice during a two-week time period and complete a survey
Giddy Penile Constriction Ring
Participants will utilize the Giddy Penile Constriction at least twice during a two-week time period and complete a survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physically and emotionally capable of engaging in sexual activity with at least one attempt per week of masturbation or sexual intercourse
Exclusion Criteria
* Men with a prior or current penile implant.
* Transgender or non-binary individuals
* Men diagnosed with a hidden or buried penis.
* Investigator's impression of expected poor participant compliance or anatomic inadequacy (penile size/girth)
* Any psychiatric disorder, which, in the opinion of the investigator, would prohibit participation.
* Coagulopathy or other blood disorder which the investigator determines would affect the participant's participation in the trial.
* Any tumor in the pelvic or penile region within the last 3 years
* Men with an active caregiver who are unable to live independently.
* Men who the provider is concerned would be at high risk for non-healing wounds of the penis.
* Participants with sensory disorders like sensory processing disorder, sensory integration dysfunction disorder, neuropathies, etc.
18 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FirmTech, Inc.
INDUSTRY
Reproductive Medicine Associates of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI RMA New Jersey
Basking Ridge, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rendon DO, Saffati G, Whitehead C, Zuckerman C, Hom A, Daily R, Khera M, Cheng PJ. Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices. J Sex Med. 2025 Jan 3;22(1):43-50. doi: 10.1093/jsxmed/qdae151.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Firmtech_RMANJ_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.